Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, et al. Cancer- and chemotherapy- induced anemia. J Natl Compr Cancer Netw. 2012;10:628–53.
CrossRef
Google Scholar
Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology (Willis-ton Park). 2015;29:282–94.
Google Scholar
de Naurois J, Novitzky-Basso I, Gill JM, Marti F, Cullen MH, Roila F. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(supplement 5):v252–6.
PubMed
CrossRef
Google Scholar
National Comprehensive Care Network I. NCCN Clinical Practice Guidlines for Oncology (NCCN Guidlines); Antiemesis. 2015.
Google Scholar
Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, et al. Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol. 2014;15:e447–60.
PubMed
CrossRef
Google Scholar
Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherpay-induced peripheral neuropathy. Current status and progress. Gynecol Oncol. 2015;140(1):176–83.
PubMed
PubMed Central
CrossRef
CAS
Google Scholar
Curigliano G, Cardinale D, Super T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, et al. On behalf of the ESMO Guidelines Working Group, Cardiovascular toxicity induced by chemo-therapy, targeted agents and radiotherapy: clinical practice guidelines. Ann Oncol. 2012;23(Supplement 7):vii155–66.
PubMed
CrossRef
Google Scholar
Ripamonti C. Management of bowel obstruction in advanced cancer. Curr Opin Oncol. 1994;6:351–7.
CAS
PubMed
CrossRef
Google Scholar
Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer. 2002;12:135–43.
PubMed
CrossRef
Google Scholar
Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Human Pathol. 1988;19:57–83.
CAS
CrossRef
Google Scholar
Kolomainen DF, Riley J, Wood J, Barton DPJ. Surgical management of bowel obstruction in gynaecological cancer. Obstet Gynaecol. 2017;19:63–70.
CrossRef
Google Scholar
Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;2000(1):CD001219.
PubMed Central
Google Scholar
Ten Broek RPG, Krielen P, Di Saverio S, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg. 2018;19(13):24.
CrossRef
Google Scholar
Catena F, Ansaloni L, Gazzotti F, et al. Small bowel tumours in emergency surgery: specificity of clinical presentation. ANZ J Surg. 2005;75(11):997–9.
PubMed
CrossRef
Google Scholar
Vallicelli C, Coccolini F, Catena F, et al. Small bowel emergency surgery: literature’s review. World J Emerg Surg. 2011;6(1):1.
PubMed
PubMed Central
CrossRef
Google Scholar
Yeo HL, Lee SW. Colorectal emergencies: review and controversies in the management of large bowel obstruction. J Gastrointest Surg. 2013;17(11):2007–12.
PubMed
CrossRef
Google Scholar
Pisano M, Zorcolo L, Merli C, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. World J Emerg Surg. 2018;13(13):36.
PubMed
PubMed Central
CrossRef
Google Scholar
Catena F, Pasqualini E, Tonini V, Avanzolini A, Campione O. Emergency surgery for patients with colorectal cancer over 90 years of age. Hepatogastroenterology. 2002;49(48):1538–9.
PubMed
Google Scholar
Takahashi H, Okabayashi K, Tsuruta M, Hasegawa H, Yahagi M, Kitagawa Y. Self-expanding metallic stents versus surgical intervention as palliative therapy for obstructive colorectal cancer: a meta-analysis. World J Surg. 2015;39(8):2037–44.
PubMed
CrossRef
Google Scholar
Rath K, Loseth D, Muscarella P, Phillips G, Fowler J, Mall D, et al. Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. Gynecol Oncol. 2013;129:103–6.
CAS
PubMed
PubMed Central
CrossRef
Google Scholar
Tamsma J. The pathogenesis of malignant ascites. Cancer Treat Res. 2007;134:109–18.
CAS
PubMed
Google Scholar
Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016;1(3):231–8.
PubMed
PubMed Central
CrossRef
Google Scholar
Hodge C, Badgwell BD. Palliation of malignant ascites. J Surg Oncol. 2019;120(1):67–73.
PubMed
CrossRef
Google Scholar
Macdonald R, Kirwan J, Roberts S, Gray D, Allsopp L, Green J. Ovarian cancer and ascites: a questionnaire on current management in the United Kingdom. J Palliat Med. 2006;9:1264–70.
PubMed
CrossRef
Google Scholar
O’Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–8.
PubMed
CrossRef
Google Scholar
Pockros PJ, Esrason KT, Nguyen C, Duque J, Woods S. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology. 1992;103:1302–6.
CAS
PubMed
CrossRef
Google Scholar
Hirte HW, Miller D, Tonkin K, Findlay B, Capstick V, Murphy J, et al. A randomized trial of paracentesis plus intraperitoneal tumor necrosis factor-α versus paracentesis alone in patients with symptomatic ascites from recurrent ovarian carcinoma. Gynecol Oncol. 1997;64:80–7.
CAS
PubMed
CrossRef
Google Scholar
Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13:273–82.
CAS
PubMed
PubMed Central
CrossRef
Google Scholar
Seimetz D, Lindhofer H, Bokemeyer C. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM × anti-CD3) as a targeted cancer immunotherapy. Cancer Treat Rev. 2010;36:458–67.
CAS
PubMed
CrossRef
Google Scholar
Skok K, Hladnik G, Grm A, Crnjac A. Malignant pleural effusion and its current management: a review. Medicina (Kaunas). 2019;55(8):490.
CrossRef
Google Scholar
Porcel JM, Diaz JP, Chi DS. Clinical implications of pleural effusions in ovarian cancer. Respirology. 2012;17:1060–7.
PubMed
CrossRef
Google Scholar
Ataseven B, Chiva LM, Harter P, Gonzalez-Martin A, du Bois A. FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited. Gynecol Oncol. 2016;142:597–607.
PubMed
CrossRef
Google Scholar
Desai NR, Lee HJ. Diagnosis and management of malignant pleural effusions: state of the art in 2017. J Thorac Dis. 2017;9:S1111–22.
PubMed
PubMed Central
CrossRef
Google Scholar
Li P, Graver A, Hosseini S, Mulpuru S, Cake L, Kachuik L, Zhang T, Amjadi K. Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study. CMAJ Open. 2018;6:E235–40.
PubMed
PubMed Central
CrossRef
Google Scholar
Sterman DH, DeCamp MM, Feller-Kopman DJ, Maskell NA, Wahidi MM, Lee YCG, Gould MK, Rahman NM, Lewis SZ, Henry T, et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198:839–49.
PubMed
CrossRef
Google Scholar
Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur J Cardiothorac Surg. 2019;55:116–32.
PubMed
CrossRef
Google Scholar
Cohen A, Lim CS, Davies AH. Venous thromboembolism in gynecological malignancy. Int J Gynecol Cancer. 2017;27:1970–8.
PubMed
CrossRef
Google Scholar
Satoh T, Matsumoto K, Tanaka YO, et al. Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment. Thromb Res. 2013;131:e127Ye132.
CrossRef
CAS
Google Scholar
Piccioli A, Falanga A, Baccaglini U, et al. Cancer and venous thromboembolism. Semin Thromb Hemost. 2006;32:694Y699.
Google Scholar
Barbera L, Thomas G. Venous thromboembolism in cervical cancer. Lancet Oncol. 2008;9:54Y60.
CrossRef
Google Scholar
Khorana AA, Dalal M, Lin J, et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013;119:648Y655.
CrossRef
CAS
Google Scholar
Barber EL, Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic oncology surgery. Gynecol Oncol. 2017;144:420–7.
PubMed
CrossRef
Google Scholar
Selby LV, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones DR, et al. Pre-operative chemoprophylaxis is safe major oncology operations and effective at preventing venous thromboembolism. J Am Coll Surg. 2016;222:129–37.
PubMed
CrossRef
Google Scholar
Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest. 2003;124:379–85.
CrossRef
Google Scholar
van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070–1090.e9.
PubMed
CrossRef
Google Scholar
Syrjala KL, Jensen MP, Mendoza ME, Yi JC, Fisher HM, Keefe FJ. Psychological and behavioral approaches to cancer pain management. J Clin Oncol. 2014;32(16):1703–11. https://doi.org/10.1200/JCO.2013.54.4825.
CrossRef
PubMed
PubMed Central
Google Scholar
Manolitas TP, Abdessalam S, Fowler JM. Chylous ascites following treatment for gynecologic malignancies. Gynecol Oncol. 2002;86:370–3.
CrossRef
Google Scholar
Al-Busafi SA, Ghali P, Deschênes M, Wong P. Chylous ascites: evaluation and management. International Scholarly Research Notices. 2014; Article ID 240473. https://doi.org/10.1155/2014/240473
Baiocchi G, Faloppa CC, Araujo RLC, et al. Chylous ascites in gynecologic malignancies: cases report and literature review. Arch Gynecol Obstet. 2010;281:677–81.
PubMed
CrossRef
Google Scholar